TD Cowen analyst Marc Frahm reiterated a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX).The analyst commented, "Ph1 expansion data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE